Military to Civilian: Trial of an Intervention to Promote Postdeployment Reintegration
M2C
Military to Civilian: RCT of an Intervention to Promote Postdeployment Reintegration
1 other identifier
interventional
1,292
1 country
1
Brief Summary
Veterans returning from combat deployments face the interrelated challenges of processing their combat experiences and transitioning back to civilian life. Unfortunately, many veterans wait years or decades before seeking help for post-deployment problems, if they seek it at all. This study seeks to determine whether Internet-Based Expressive Writing (IB-EW), a brief, low-cost, easily disseminated, and resource-efficient intervention, can reduce psychological symptoms and improve functioning among Operation Iraqi Freedom (OIF) and Operation Enduring Freedom (OEF) veterans as they navigate this transition, while also attempting to reduce barriers to help-seeking. Expressive Writing, a highly private, readily accessible, and non-stigmatizing intervention, has a strong evidence-base in civilian populations, but its efficacy in combat veterans has not been tested. This study therefore seeks to test the efficacy of Expressive Writing in a veteran population while further enhancing its accessibility by delivering it over the internet (Internet-Based Expressive Writing; IB-EW). This study will comprise a randomized controlled trial with three conditions: (a) Internet-Based Expressive Writing, (b) Internet-Based Control Writing, and (c) No Writing/Treatment As Usual, with a total of 1152 OIF/OEF veterans randomized across these groups. Expressive Writing participants will write with feeling about their transition from being a soldier to being a civilian; Control Writing participants will write factually about the information needs of new veterans; and Treatment as Usual participants will complete the assessments but not engage in any writing assignments. Participants will complete standardized self-report measures of psychological symptoms, psychosocial functioning, and life satisfaction at baseline (Session 1) and at three months (Session 6) and six months (Session 7) post-intervention. Participants in writing conditions will write for 20 minutes on four consecutive days (Sessions 2-5) following completion of baseline measures (participants in the TAU condition will not complete Sessions 2-5). The study will also attempt to identify individual difference characteristics related to the efficacy of the treatment, to see who may be most likely to benefit from the treatment. Analyses will primarily entail multivariate analyses of variance. Power is adequate to detect even a small effect.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Jun 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2008
CompletedFirst Posted
Study publicly available on registry
March 21, 2008
CompletedStudy Start
First participant enrolled
June 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2013
CompletedSeptember 23, 2015
September 1, 2015
1.8 years
March 18, 2008
September 21, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
PTSD symptoms
Baseline, 3-month, 6-month
Hostility
Baseline, 3-month, 6-month
Psychological distress
Baseline, 3-month, 6-month
Physical symptoms
Baseline, 3-month, 6-month
Reintegration difficulty
Baseline, 3-month, 6-month
Social support
Baseline, 3-month, 6-month
Life satisfaction
Baseline, 3-month, 6-month
Secondary Outcomes (2)
Emotion and causal word use in participants' essays
Intervention Sessions (up to 4 sessions post-baseline for participants assigned to a writing condition)
Employment status
Baseline, 3-month, 6-month
Study Arms (3)
Expressive Writing
EXPERIMENTALParticipants assigned to the Expressive Writing (EW) condition will write about their deepest thoughts and feelings associated with their experience transitioning from being a soldier to being a civilian for 20 minutes a day for 4 days within a week.
Control Writing
ACTIVE COMPARATORThose assigned to control writing condition will write factually about the information needs of veterans transitioning from active duty to civilian status for 20 minutes on 4 days within one week.
No Writing Control
NO INTERVENTIONTreatment As Usual
Interventions
In EW, people are asked to write about their deepest thoughts and feelings surrounding a significant life event for 20 minutes a day for 4 days
Those assigned to control writing conditions are asked to describe factual information for 20 minutes a day for 4 days.
Eligibility Criteria
You may qualify if:
- Veteran from current wars in Iraq and Afghanistan
- At least a little difficulty transitioning from soldier to civilian
- Access to computer with internet
- Provide valid contact information
- Available to participate for up to 40 minutes per session
- Interested in participation
- Understand procedures and consent
- Note: participants are recruited by random selection from the target population
You may not qualify if:
- Severe depression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minneapolis Veterans Affairs Medical Centerlead
- United States Department of Defensecollaborator
- US Department of Veterans Affairscollaborator
Study Sites (1)
VA Medical Center
Minneapolis, Minnesota, 55417, United States
Related Publications (1)
Sayer NA, Orazem RJ, Noorbaloochi S, Gravely A, Frazier P, Carlson KF, Schnurr PP, Oleson H. Iraq and Afghanistan War Veterans with Reintegration Problems: Differences by Veterans Affairs Healthcare User Status. Adm Policy Ment Health. 2015 Jul;42(4):493-503. doi: 10.1007/s10488-014-0564-2.
PMID: 24913102RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nina A Sayer, PhD
Minneapolis Veterans Affairs Medical Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- FED
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Director, CCDOR; Research Director, PTBRI QUERI
Study Record Dates
First Submitted
March 18, 2008
First Posted
March 21, 2008
Study Start
June 1, 2011
Primary Completion
April 1, 2013
Study Completion
September 1, 2013
Last Updated
September 23, 2015
Record last verified: 2015-09